Endoscopic ultrasound-guided gastroenterostomy for the treatment of gastric outlet obstruction secondary to acute pancreatitis
- PMID: 39529322
- DOI: 10.1055/a-2452-5307
Endoscopic ultrasound-guided gastroenterostomy for the treatment of gastric outlet obstruction secondary to acute pancreatitis
Abstract
Background: Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is a minimally invasive technique for treating gastric outlet obstruction (GOO). The aim of this study was to assess the outcomes of EUS-GE in managing benign GOO caused by duodenal stenosis in patients with acute pancreatitis.
Methods: This international retrospective study analyzed patients treated with EUS-GE for GOO caused by acute pancreatitis until December 2023, evaluating technical and clinical success, adverse events, and reintervention.
Results: 39 patients (median age 55 years, 15 women) were included. There was a 92.3% technical success rate, with only three patients unable to undergo EUS-GE owing to a long distance between the stomach and small bowel or an inadequate window for puncture. Clinical success was observed in 34 patients (87.2%). The median Gastric Outlet Obstruction Scoring System (GOOSS) improved from 0 before EUS-GE to 2 afterward (P <0.001). Follow-up (≥3 months) was available in 25 patients. During a median follow-up of 23 months, four patients required reintervention. It was possible to remove the lumen-apposing metal stent in 18 patients. The only adverse event was a gastrocolic fistula detected incidentally after 3 months.
Conclusion: EUS-GE is an effective and safe method for managing benign GOO in the setting of acute pancreatitis.
Thieme. All rights reserved.
Conflict of interest statement
A. Wannhoff received a research grant from Fujifilm Medwork GmbH and OVESCO Endoscopy AG and received lecture fees from OVESCO Endoscopy AG. R.Z. Sharaiha is a consultant for Boston Scientific, Olympus, Cook Medical, and Surgical Intuitive. T.H. Baron is a consultant and speaker for Boston Scientific, W.L.Gore, Cook Endoscopy, and Olympus America. S.S. Irani is a consultant for Boston Scientific and Gore. A. Canakis, F. Fayyaz, C. Schlag, N. Sharma, I. Elsayed, M.A. Khashab, and K. Caca declare that they have no conflict of interest.